NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

FS KKR Capital Corp. Plunges 18% on Deeper Dividend Cut

FS KKR Capital Corp., a business development company jointly managed by Future Standard and KKR & Co., experienced a significant decline in its stock price of up to 18% on Thursday, the largest intraday drop since 2020. The company's decision to slash its quarterly dividend to 48 cents per share from 70 cents, a cut more substantial than the previously signaled reduction of 55 cents, contributed to the decline.

The FS KKR Capital Corp. portfolio faced challenges, with 3.4% of its assets, or approximately $440 million, on non-accrual status at year-end, up from 2.9% three months earlier. The company attributed the decline in earnings to lower interest rates and losses from troubled investments. Michael Forman, Chief Executive Officer, stated that "specific challenges associated with a few investments" weighed on results.

During the fourth quarter, loans to Dental Care Alliance, Gracent, and Lionbridge Technologies were placed on non-accrual status, as well as investments in AmeriVet Partners and Alacrity Solutions. FS KKR marked down its loan to software company Medallia to about 79 cents on the dollar from 91 cents in the prior quarter.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Investor Takeaway

Investors should be cautious of dividend reduction and portfolio impairments in private credit funds.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.